-
Optical fibre cable makerās invalidation claims were āvaliantā but āfell flatā, EWHC rules in Fujikura v. Sterlite patent infringement decision
Read more: Optical fibre cable makerās invalidation claims were āvaliantā but āfell flatā, EWHC rules in Fujikura v. Sterlite patent infringement decisionThe High Court of Justice for England & Wales has ruled that a patent asserted by Japanese electrical equipment manufacturer Fujikura is valid and has been infringed by a range of Indian rival Sterliteās fiber optic cables.
-
U.S. and Asian companies bring vast majority of major Unified Patent Court infringement cases, reflective of EU weakness in innovation
Read more: U.S. and Asian companies bring vast majority of major Unified Patent Court infringement cases, reflective of EU weakness in innovationAbout one third of the last 100 UPC infringement actions were brought by companies headquartered in a contracting member state, but most of them are small.
-
GUEST ARTICLE: Cellular SEP aggregate royalty rate for carrier network equipment
Read more: GUEST ARTICLE: Cellular SEP aggregate royalty rate for carrier network equipmentThe following article was authored by Professor John Gong of the Department of Economics of the University of International Business and Economics (Beijing). Guest articles reflect the opinions of their authors, not those of ip fray. As smartphone manufacturers like Apple, Xiaomi and OPPO have accumulated more and more standard-essential patents (SEP), making into the…
-
UPC Roundup (1 week): contempt sanctions over continued shipments; Dusseldorf LD ordered inspection at Munich trade fair; three injunctions
Read more: UPC Roundup (1 week): contempt sanctions over continued shipments; Dusseldorf LD ordered inspection at Munich trade fair; three injunctionsThis is a summary of developments in and around the Unified Patent Court (UPC) in the week since our November 30, 2025 UPC Roundup.
-
Halozyme wins Munich PI against Merck’s Keytruda SC (subcutaneous immunotherapy); meanwhile, litigators await appointment of Judge Werner’s successor
Read more: Halozyme wins Munich PI against Merck’s Keytruda SC (subcutaneous immunotherapy); meanwhile, litigators await appointment of Judge Werner’s successorOn Thursday, Halozyme obtained a preliminary injunction against Merck’s Keytruda SC.
-
UK consultation on SEP legislation closed two months ago, and they can already scrap their plans because of what has happened since
Read more: UK consultation on SEP legislation closed two months ago, and they can already scrap their plans because of what has happened sinceThe UK government gave stakeholders 12 weeks to comment on its vision of global FRAND resolution, but the following month the landscape changed.
-
USPTO Director Squires encourages fairer, more consistent patent eligibility in latest memoranda
Read more: USPTO Director Squires encourages fairer, more consistent patent eligibility in latest memorandaUSPTO Director John A. Squires reminds applicants and examiners that when used properly, Subject-Matter Eligibility Declarations can be effective, encouraging examiners not to reject patent applications too broadly.
-
Netflix now has exclusive merger talks with Warner Bros. Discovery despite Trump-aligned Paramount having raised antitrust concerns
Read more: Netflix now has exclusive merger talks with Warner Bros. Discovery despite Trump-aligned Paramount having raised antitrust concernsGiven the current wave of patent enforcement actions against video streamers, including Nokia v. Warner Bros. Discovery, we exceptionally share some thoughts on a proposed streaming merger with upstream implications for the video patent licensing market.


